SEYCHELLE PRENTICE: Open Payments
NPI 1275091928 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 29 payments from 13 companies in 2025. Trend: 2023 $462 · 2024 $795 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Kestra Medical Technology Services, Inc. | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Amgen Inc. | 5 | $85 |
| Alnylam Pharmaceuticals Inc. | 2 | $71 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| PFIZER INC. | 1 | $27 |
Products named: LOKELMA, Assure WCD, LEQVIO, REPATHA, ONPATTRO, VERQUVO, FUROSCIX, JARDIANCE.
Industry payments across FL — which companies pay providers there.
